Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells.

Saved in:
Bibliographic Details
Title: Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells.
Authors: Kim J; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.; Department of Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea., Han Q; AntiCancer Inc., San Diego, CA, United States., Li S; AntiCancer Inc., San Diego, CA, United States., Kang BM; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States., Miyashi Y; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States., Ishiguro T; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States., Bouvet M; Department of Surgery, University of California, San Diego, San Diego, CA, United States., Hoffman RM; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.
Source: Frontiers in oncology [Front Oncol] 2026 Jun 03; Vol. 16, pp. 1807785. Date of Electronic Publication: 2026 Jun 03 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42318457
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kim+J%22">Kim J</searchLink>; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.; Department of Surgery, Chungnam National University College of Medicine, Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Han+Q%22">Han Q</searchLink>; AntiCancer Inc., San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Li+S%22">Li S</searchLink>; AntiCancer Inc., San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Kang+BM%22">Kang BM</searchLink>; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Miyashi+Y%22">Miyashi Y</searchLink>; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Ishiguro+T%22">Ishiguro T</searchLink>; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Bouvet+M%22">Bouvet M</searchLink>; Department of Surgery, University of California, San Diego, San Diego, CA, United States.<br /><searchLink fieldCode="AU" term="%22Hoffman+RM%22">Hoffman RM</searchLink>; AntiCancer Inc., San Diego, CA, United States.; Department of Surgery, University of California, San Diego, San Diego, CA, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568867%22">Frontiers in oncology</searchLink> [Front Oncol] 2026 Jun 03; Vol. 16, pp. 1807785. <i>Date of Electronic Publication: </i>2026 Jun 03 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101568867 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>2234-943X (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222234943X%22">2234943X </searchLink><i>NLM ISO Abbreviation: </i>Front Oncol <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42318457
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fonc.2026.1807785
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1807785
    Titles:
      – TitleFull: Direct comparison of efficacy of combining ivermectin versus five first-line chemotherapy drugs with recombinant methioninase against colon-cancer cells.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kim J
      – PersonEntity:
          Name:
            NameFull: Han Q
      – PersonEntity:
          Name:
            NameFull: Li S
      – PersonEntity:
          Name:
            NameFull: Kang BM
      – PersonEntity:
          Name:
            NameFull: Miyashi Y
      – PersonEntity:
          Name:
            NameFull: Ishiguro T
      – PersonEntity:
          Name:
            NameFull: Bouvet M
      – PersonEntity:
          Name:
            NameFull: Hoffman RM
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 03
              M: 06
              Text: 2026 Jun 03
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-print
              Value: 2234-943X
          Numbering:
            – Type: volume
              Value: 16
          Titles:
            – TitleFull: Frontiers in oncology
              Type: main
ResultId 1